PROBLEM TO BE SOLVED: To provide c-Met kinase inhibitors and pharmaceutical compositions useful for cancer and diseases caused by the dysregulation of kinase pathways.SOLUTION: The present invention provides dihydrochloric acid salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide represented by formula (I) and hydrates or solvates thereof, and pharmaceutical compositions containing them. The hydrates have melting points of 220-224°C, preferably 222°C.【課題】癌及びキナーゼ経路調節異常による疾患に有用な、c-Metキナーゼ阻害剤、医薬組成物の提供。【解決手段】式(I)で表される、2-フルオロ-N-メチル-4-[7-(キノリン-6-イルメチル)イミダゾ[1,2-b][1,2,4]トリアジン-2-イル]ベンズアミドの二塩酸塩、及びその水和物又は溶媒和物、並びにそれらを含む医薬組成物。前記水和物は220~224℃の融点、好ましくは222℃の融点を持つ式(I)で表わされる化合物。【選択図】図1